Get started
Author

Agatha Almela-Gallego

Observed names: Agatha Almela, Ágata Almela, Ágata Almela Gallego
Observed institution: Hospital Universitario de León
ORCID: 0000-0001-8733-3171
Observed ORCID: 0000-0001-8733-3171
OpenAlex ID: A5134611017
Prognostic impact of variant allele frequency in intensively treated patients with NPM1 -mutated AML: a PETHEMA study
2026 · José Vicente Gil, Claudia Sargas, et al. · Blood · 1
Measurable residual disease assessment as an early end point of treatment efficacy in acute myeloid leukemia: a multinational PETHEMA study of 2623 patients treated with intensive therapy
2026 · Bruno Paiva, Leire Burgos, et al. · Leukemia
Venetoclax-based therapy versus hypomethylating agents alone in unfit patients with newly diagnosed acute myeloid leukemia: a real-world study from the PETHEMA registry
2026 · Gaspar Aspas Requena, Eliana Aguiar, et al. · Leukemia
PDF
Validation of ELN 2024 genetic classification in patients with AML treated with HMA-based regimens: PETHEMA registry study
2026 · Eva Barragán, José Vicente Gil, et al. · Blood Neoplasia
CEBPA ‐bZIP Mutations in AML Patients Treated With Non‐Intensive Therapy: A Study by the Spanish PETHEMA Registry
2026 · Esther Prados de la Torre, Josefina Serrano, et al. · Hematological Oncology
Works count: 5
Citation count: 1
H-index: 1
I10-index:
Year
Topic
Type